0.0020
+0.0005
+(33.33%)
At close: January 10 at 3:00:00 PM EST
Breakdown
TTM
3/31/2023
3/31/2022
3/31/2021
Operating Cash Flow
-2,583.7060
-7,399.0350
-4,518.4000
-5,056.1300
Investing Cash Flow
-15.6450
-1,128.4490
-609.0020
-1,306.3270
Financing Cash Flow
1,190.6960
1,236.4150
2,704.0110
14,411.8960
End Cash Position
83.9380
1,462.3110
8,677.6140
11,101.0050
Capital Expenditure
-42.6450
-902.5880
-25.2100
--
Issuance of Capital Stock
--
1,264.2190
2,642.4080
13,920.2590
Issuance of Debt
--
--
--
60.0000
Repayment of Debt
-73.5230
-27.8040
-11.3880
-22.2720
Free Cash Flow
-2,626.3510
-8,301.6230
-4,543.6100
-5,056.1300
3/31/2021 - 3/25/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
MYNDF MYND Life Sciences Inc.
0.0125
0.00%
IVBXF Innovent Biologics, Inc.
4.5294
0.00%
CFRXQ ContraFect Corporation
0.0001
0.00%
HAVLF HAVN Life Sciences Inc.
0.0010
0.00%
BXRXQ Baudax Bio, Inc.
0.0000
0.00%
BIOA-B.ST BioArctic AB (publ)
206.80
+1.08%
DMYD-B.ST Diamyd Medical AB (publ)
17.14
-5.20%
AVBP ArriVent BioPharma, Inc.
24.88
-7.37%
ABVX ABIVAX Société Anonyme
6.38
-4.49%
RLYB Rallybio Corporation
0.9400
-5.63%